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Abstract
Background: Given the continuing co-circulation of the 2009 H1N1 pandemic influenza A viruses with seasonal H3N2
viruses, rapid and reliable detection of newly emerging influenza reassortant viruses is important to enhance our influenza
surveillance.
Methodology/Principal Findings: A novel pyrosequencing assay was developed for the rapid identification and subtyping
of potential human influenza A virus reassortants based on all eight gene segments of the virus. Except for HA and NA
genes, one universal set of primers was used to amplify and subtype each of the six internal genes. With this method, all
eight gene segments of 57 laboratory isolates and 17 original specimens of seasonal H1N1, H3N2 and 2009 H1N1 pandemic
viruses were correctly matched with their corresponding subtypes. In addition, this method was shown to be capable of
detecting reassortant viruses by correctly identifying the source of all 8 gene segments from three vaccine production
reassortant viruses and three H1N2 viruses.
Conclusions/Significance: In summary, this pyrosequencing assay is a sensitive and specific procedure for screening large
numbers of viruses for reassortment events amongst the commonly circulating human influenza A viruses, which is more
rapid and cheaper than using conventional sequencing approaches.
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Introduction
Influenza A viruses contain 8 negative strand RNA segments
encoding 11 proteins including polymerase basic protein 2 (PB2)
and 1 (PB1), PB1-F2, polymerase acidic protein (PA), hemagglu-
tinin (HA), nucleoprotein (NP), neuraminidase (NA), matrix
protein 1 and 2 (M1 and M2), and non-structural protein 1 and
2 (NS1 and NS2) [1]. When different subtypes of influenza A
viruses co-infect a cell, they can exchange their gene segments and
produce novel viruses with new genotypes, a process known as
reassortment. Reassortment plays a pivotal role in the evolution of
influenza viruses, and the recent 2009 H1N1 pandemic virus
(H1N1pdm) was the result of multiple reassortment events
between human, avian and swine influenza A viruses [2,3].
Since the outbreak of the 2009 pandemic, H1N1pdm has
quickly become a dominant influenza strain circulating through-
out the world, although seasonal H3N2, as well as influenza B
viruses, continue to co-circulate.
Co-infection of H1N1pdm with seasonal H1N1 or H3N2
viruses was sometimes detected in patients [4], and hence it is
possible that reassortants might arise from these viruses or other
animal influenza viruses. Indeed, there have been several reported
cases so far where the H1N1pdm subtype was reassorted with
swine influenza viruses [5,6,7]. Fortunately, these reassortants
were self-limited and did not spread further into the wider
population. Nevertheless, these cases highlight the urgent need for
the development of a rapid and robust method that allows any
further reassortment of the H1N1pdm virus to be quickly
identified before it can spread further. At present, influenza virus
reassortants can be detected by full-genome sequencing, although
this is accurate, it is a time-consuming and labor-intensive
technique that is not able to be done in many laboratories.
Recently, real-time RT-PCR methods have also been developed to
detect known reassortants between H1N1pdm and seasonal H1N1
viruses [4,8,9], however, these assays are limited in that no
sequence data could be generated.
Pyrosequencing is a relatively new technology that is based on
the principle of sequencing by synthesis [10]. It has the capacity of
generating accurate sequence information for at least 50
nucleotides in real-time, and the capacity of high throughput
screening of up to 96 samples within one hour. Combining the
benefits of both sequencing and real-time PCR, pyrosequencing
has been widely used in influenza molecular surveillance for SNP
detection and mutation screening, such as antiviral resistant
mutations [11,12,13,14,15]. However, these methods are designed
to only detect point mutations within its short target region. Here
we report for the first time the development of a pyrosequencing-
based assay that is capable of not only subtyping human influenza
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H1N1pdm, seasonal H1N1 and H3N2 based on signature
sequences (15–30 bp) from all eight gene segments.
Results
Pyrosequencing assay development
The nucleotide sequences of selected viruses from the
influenza A subtypes H1N1, H3N2, and H1N1pdm were
downloaded from NCBI influenza database (http://www.ncbi.
nlm.nih.gov/genomes/FLU/Database). In general, all internal
genes (PB2, PB1, PA, NS, NP and M) across the three subtypes
shared high sequence homology, therefore the same PCR and
sequencing primers were designed to target the conserved region
of all three subtypes to minimize the number of primer sets used
in this assay. Due to the high sequence variation within the HA
and NA regions from the H1N1 and H3N2 subtypes, two pairs
of primers were designed, one specific for H3N2, the other
targeting both H1N1pdm and seasonal H1N1 (except for the N1
forward primer). Then a sequencing primer was designed which
targeted the conserved regions of all viruses immediately
adjacent to a region that was diverse between different subtypes
but highly conserved within the same subtypes. When
pyrosequencing was performed with these sequencing primers
using a pre-designed sequencing order, different subtypes of
influenza A could be distinguished with the short signature
sequences (varied from 15 to 30 bp) unique to each of the genes.
A set of representative pyrograms is shown in Figure 1, clearly
depicting three different signature sequences of the PA gene
segments for H1N1pdm, H3N2 and the seasonal H1N1. The
sequences obtained were then analysed using the Identifier
program and compared with the reference sequences in a
purpose-built library containing the signature sequences of each
gene from all subtypes. Automatic detection of subtype and gene
segment was generated for each sequence, and a score was also
given to indicate how strong the homology was to the reference
sequence. To gain as much information as possible, the regions
to be pyrosequenced also covered different gene regions of
interest; for example, the HA sequence of H3N2 could be
further differentiated between the two lineages (A/Brisbane/10/
2007 and A/Perth/16/2009), and the NA sequences to be
distinguished from the wild-type oseltamivir-sensitive H275 and
oseltamivir-resistant H275Y mutation, and the M2 sequences to
be differentiated from adamantane sensitive S31 and the N31
adamantane resistant viruses.
The pyrosequencing assay was first evaluated on 57 viruses
isolated from MDCK virus isolates which were typed/subtyped by
real-time RT-PCR. This included 13 seasonal H1N1, 16 H3N2,
28 H1N1pdm viruses sampled from 2007 to 2010. All 57 viruses
were identified correctly for their subtypes and/or clades for all 8
genes. Moreover the data also provided further information on the
NA and MP genes to identify whether they had acquired the
H275Y oseltamivir-resistance mutation in the NA or the S31N
adamantane-resistance mutation in the M2 protein. All of the
eight genes from all 49 viruses were from the currently circulating
subtypes, ie H1N1pdm, H3N2 or seasonal H1N1. No reassortant
virus was detected. Further conventional full genome sequencing
of eight viruses (4 H1N1pdm, 2 seasonal H1N1, 2 H3N2)
confirmed the pyrosequencing results.
The specificity of this pyrosequencing method was tested on a
number influenza B viruses, and none of them could be detected
by any of the 8 gene segments (data not shown), demonstrating
that the assay was highly specific to influenza A viruses.
Subtyping of influenza viruses from original specimens
To further test the usefulness of this assay on original specimens,
31 human influenza A samples with Ct values from 20–30 for
influenza A M gene were chosen for pyrosequencing, including 23
pdmH1N1 and 8 H3N2. Seventeen of them (54%) were correctly
subtyped for all 8 genes, with a median Ct value of 22.5 (range 20–
27); whereas 14 samples with a median Ct value of 28.5 (range 28–
30) could only be partially subtyped by 2–7 genes, but the
subtyping results obtained were consistent with the real-time RT-
PCR results. This association with Ct value suggested that the lack
of pyrosequencing signals for some of the samples was most likely
caused by the lower viral loads in these samples.
Identification of reassortant viruses
The ability of this assay to identify any reassortant virus with
mixed genes from different subtypes was tested on 5 viruses,
including the vaccine production reassortant viruses IVR-148 (A/
Brisbane/59/2007), IVR-153 (A/California/07/2009) and IVR-
157 (A/Victoria/208/2009), and three H1N2 viruses (A/Bang-
kok/335/2000, A/Singapore/44/2000 and A/Singapore/63/
2001). All genes were correctly classified into their corresponding
subtypes for these viruses (Table 1), indicating the robustness of
this pyrosequencing method to identify any potential reassortant
virus.
Identification of influenza A viruses with unknown
subtypes
Six original human influenza A clinical samples whose subtypes
could not be identified previously by real-time RT-PCR were
selected for pyrosequencing assay in an attempt to determine their
subtypes. The results showed that two of the samples with Ct
values of 27 and 29 were identified as H1N1pdm for all eight
genes, whereas the other four samples with a Ct value between 30
to 33 failed to generate PCR products and subsequent sequencing
data. Although the primers were designed to detect human
influenza A viruses, some internal primers, such as MP and NS
could theoretically also work on most of avian influenza A viruses
based on bioinformatics analysis (data not shown). Therefore, the
negative results were most likely caused by the low viral loads of
these samples.
Discussion
The 2009 influenza A H1N1 pandemic viruses are continuously
evolving, and there is a concern that they may acquire gene
segments through reassortment with other circulating viruses from
both human and animal sources to produce a new virus which
could have higher pathogenicity in man. The H1N1pdm virus is
already a product of multiple reassortment events [2], and it is
possible that it could reassort with the currently circulating H3N2
virus to generate H1N2 viruses as happened with seasonal H1N1
and H3N2 viruses in early 2000 [16,17] or viruses with reassorted
internal genes.
It has been a challenge to detect reassortant viruses in a quick
and robust way. There are a number of methods that have been
used for reassortment detection, including real-time RT-PCR
[4,8,9], conventional RT-PCR and conventional sequencing. The
pyrosequencing assay reported here combines the benefits of some
of these methods as it is a fast and high-throughput method that
only takes about 4 hours to detect all eight gene segments of up to
12 viruses. Furthermore, the method is very accurate and sensitive,
and can be used for both original clinical specimens (providing
there are sufficient viruses in the sample) and cell or egg grown
viruses. Most importantly, with a total of 10 sets of primers, all
Influenza Reassortant Detection by Pyrosequencing
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reassortant viruses could be accurately subtyped by short
sequences without prior knowledge of the virus genome. Clearly,
this is not possible for real-time RT-PCR, since specific probes are
needed for each gene from each subtype to determine the subtypes
of each gene segments. Hence, the pyrosequencing method can
greatly reduce the workload and cost of testing for reassrotment.
However, the requirement of the PyroMark instrument for this
assay might limit its use in some developing countries, as this
device is currently not as widely used as conventional sequencers
which are available in many laboratories. Another limitation of the
assay is that it can only accurately sequence up to 50 bases, so is
not suitable for full genome sequencing.
Reassortment events between seasonal influenza viruses were
occasionally observed and reported previously in several countries
[18,19,20]. Sometimes viral co-infection could be mistaken as
reassortant virus. As a proof of concept, we have demonstrated the
usefulness of this pyrosequencing method in detecting potential
reassortant viruses by successful identification of the sources of all
eight genes of the three vaccine production reassortant viruses
IVR-148, IVR-153 and IVR-157, as well as three H1N2 viruses
previously identified.
The pyrosequencing method was found to be more suitable for
use with virus isolates than original specimens. It has a 100%
success rate for isolates, whereas successful detection of all eight
genes in original specimens depended on the quantity and possibly
Figure 1. Pyrograms of PA gene segment of H1N1pdm, H3N2, and seasonal H1N1 viruses. The y axis represents the luminescence
intensity, of which the peak heights are proportional to the number of each nucleotide incorporated at one time. The order of enzyme (E), substrate
(S), and sequential nucleotide addition is indicated on the x axis. (a) A/Auckland/1/2009 (H1N1pdm) sequence GATTACAGGAACTATGCGCAAG. (b) A/
Brisbane/10/2007 (H3N2) sequence AATCACAGGACAATGCGCAGG. (c) A/Brisbane/59/2007 (seasonal H1N1) sequence AATCTCAGGAACTATGCGCAGG.
doi:10.1371/journal.pone.0023400.g001
Table 1. Pyrosequencing result for reassortant viruses.
Virus Gene Subtype
1
HA NA PB2 PB1 PA MP NP NS
IVR-148 H1N1 H1N1 PR8 H3N2 PR8 PR8 PR8 PR8
IVR-157 H3N2 H3N2 PR8 PR8 PR8 PR8 PR8 H3N2
IVR-153 H1N1pdm H1N1pdm PR8 H3N2 PR8 PR8 PR8 PR8
A/Bangkok/335/2000 H1N1 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2
A/Singapore/44/2000 H1N1 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2
A/Singapore/63/2001 H1N1 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2 H3N2
1Subtype of each gene was determined by automatic comparison to the purpose-built library using Identifier. Signature sequences of the consensus sequences for each
gene from H1N1, H3N2, pdmH1N1, as well as the sequence from A/Puerto Rico/8/1934 (PR8) are included in the library.
doi:10.1371/journal.pone.0023400.t001
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detect samples with a moderate viral load, with a Ct value of less
than 30 for influenza A M gene (which corresponds to about 5000
copies of matrix RNA in the reaction). Nevertheless, information
on some, if not all eight gene segments from some original
specimens may be sufficient for influenza A virus subtyping, as
real-time RT-PCR method only relies on one or two genes for
subtyping.
Apart from detecting reassortment, this method could also be
applied to determine the subtype of viruses. Real-time RT-PCR is
currently the most widely used assay for influenza virus typing and
subtyping. However, occasionally it can fail when samples have
mismatches in either the primer or probe binding regions. The
pyrosequencing primers we designed here target the highly
conserved regions of human influenza A viruses, therefore they
may have a higher chance of detecting all subtypes of human
influenza A. By detecting all eight genes, rather than targeting one
or two genes as with real-time RT-PCR, pyrosequencing is more
likely to detect virus subtypes accurately. A number of human
influenza A viruses which could not be subtyped by real-time RT-
PCR were successfully identified as H1N1pdm viruses by our
pyrosequencing assay.
Using this method, we demonstrated that we could clearly
distinguish between the human seasonal H1N1, H3N2 and
H1N1pdm viruses that circulated in both the northern and
southern hemisphere in 2008, 2009 and 2010. Moreover, the assay
was able to differentiate between the two H3N2 lineages (A/
Brisbane/10/2007 and A/Perth/16/2009) based on H3 HA
sequence, the H275 oseltamivir-sensitive wild-type and H275Y
oseltamivir-resistant mutant viruses based on N1 NA sequences,
and the S31 amantadine-sensitive wild-type and N31 amantadine-
resistant mutant viruses based on M2 sequence. These primers
were also tested on several influenza vaccine strains which were
reassortants and were able to correctly identify them as
reassortants (Table 2). This method extends the more conventional
use of pyrosequencing in influenza surveillance where it is mainly
used for the identification of molecular markers of resistance to
antiviral drugs [11,12,13,14,15].
This pyrosequencing assay also has the potential to identify new
influenza viruses, since the primers were designed in the highly
conserved regions across different human influenza A subtypes.
Although the primers were primarily designed for human
influenza A viruses, some of the internal gene primers, especially
MP and NS primers could also amplify most of the avian influenza
A subtypes based on bioinformatics analysis, therefore at least one
or more genes from some influenza A viruses with an avian origin
could be successfully amplified and sequenced into unknown
regions by de novo sequencing of at least 30–40 bases, which could
provide enough information to identify new influenza viruses using
a BLAST analysis. Even if a gene segment from a disparate animal
source was encountered, a negative result would flag an unusual
outcome and the whole gene segment could be further sequenced
using conventional Sanger sequencing to type the reassortant.
In conclusion, for the first time we report a high-throughput
pyrosequencing method for rapid identification of potential
influenza A reassortant viruses derived from currently circulating
subtypes. This method could also be further adapted to detect
genes originating from other subtypes, such as avian influenza A
subtypes H5N1, H3N8, etc by modifying some of the primers.
This method is capable of facilitating the rapid identification of
any new emerging reassortant influenza viruses in the future.
Materials and Methods
Clinical samples and virus isolates
Clinical specimens and virus isolates from Oceania and Asia
were received at the WHO Collaborating Centre for Reference
and Research on Influenza, Melbourne, Australia, as part of the
WHO Global Influenza Surveillance Network. Viruses were
isolated in Madin-Darby canine kidney (MDCK) cells (American
Type Culture Collection (CCL-34)) using maintenance media
(DMEM Coon’s Basal Media containing sodium bicarbonate (3%)
with the addition of 2 mM glutamine, 1% non-essential amino
acids, 0.05% NaHCO3, 0.02 M HEPES, 4% penicillin and
streptomycin, 2 mg/ml amphotericin B and 4 mg/ml trypsin (CSL
Biotherapies)).
RNA extraction and real-time RT-PCR
Viral RNA was extracted from clinical specimens or MDCK
cell culture supernatants using either the QIAmp Viral RNA Mini
Kit (QIAGEN) or the MagnaPure extraction system (Roche)
according to the manufacturer’s protocols. Real-time RT-PCR
was performed on original clinical specimens to determine the type
and subtype of the viruses using Superscript III one-step qRT-
PCR kit (Invitrogen, Carlsbad, CA) with specific primers and
Table 2. Primers for reassortment pyrosequencing.
Subtype Gene Forward Primer Reverse Primer Sequencing Primer
Seasonal and H1N1pdm HA 5*TGGACWGGRATGGTAGATG TGAACTCTTTRCCYACTGCTGTGAAC AATGGCATTYTGTGTGCT
Seasonal H1N1 NA 5*ACAATGGRGCWGTGGCTG TGCCAGTTRTCCCTGCAYACACA TAACAGGAGCATTCCTCATA
H1N1pdm NA 5*GACAGGCCTCATACAAGATCTTC TGCCAGTTRTCCCTGCAYACACA TAACAGGAGCATTCCTCATA
H3N2 HA ACTCAAAAYGGAACAAGCTC 5*TGTGATTCTTCCTRATGCTTG CTGCTTGCAWAAGGARATCT
H3N2 NA ACTGATGGGAGTGCKTCA 5*TCCTGAACACACATAWCTGG TTGTCAGGARGTGCTCAG
Human Influenza A PB2 GTGTCAGCAGAYCCAYTAGCATC 5*TTGCCYGTDAGCACYTCTTC ATGTGCCAYAGCAC
PB1 GAYGCYGTTGCAACWACAC 5*ATGGTGGAACAGATCTTCATGATCTC GTAYCAGRGTGCTGCAA
PA CCTTTCGTCAGTCCGAAAGAGG 5*TTGCCCTCAATGYAGCCGTTC ACAATTGAAGAAARATTTGA
MP 5* TTGGGACTCATCCTAGCTC ACTCCTTCCGTAGAAGGSCCTCT GTGCAMRATCCCAAT
NS GATGCCCCMTTCCTTGATCG 5*GGCATKAGCATGAACCAG GAGRCACTTARAATGAC
NP 5*CGGAATGGATCCCAGRAATGTG ATCTCAGYRTTTCCTGGGT GCACATTCTYTCATAAGCA
5*: indicates the primer is biotinylated at the 59 end.
doi:10.1371/journal.pone.0023400.t002
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Foster City, CA).
RT-PCR and pyrosequencing
cDNA was first produced from viral RNA with universal
influenza RT primers (Hoffman paper ref) using ThermoScript
TM
RT-PCR System for First-Strand cDNA Synthesis (Invitrogen),
then PCR amplification was carried out using high fidelity
Platinum Taq DNA polymerase (Invitrogen) with 10 sets of
primers in which either the forward or reverse primer was
biotinylated (Geneworks, Adelaide, Australia) to amplify all eight
genes for pyrosequencing (Table 2). PCR was done in a 50 ml
reaction volume as follows: 50uC 30 min, 94uC 2 min, then 40
cycles of 94uC3 0s ,5 5 uC3 0s ,6 8 uC 30 sec, then a final extension
at 68uC for 1 min. Single-stranded biotinylated DNA from the
RT-PCR product was generated and purified using the PyroMark
Vacuum Prep Workstation (Qiagen, Valencia, CA) according to
the manufacturer’s recommendation. Briefly, biotinylated PCR
amplicons were bound to streptavidin-coated beads, and were
then subjected to denaturation and washing to generate single
stranded DNAs, which were then released to a PSQ plate prefilled
with 40 ml annealing buffer containing pyrosequencing primer
(100 mM). The sample plate was heated at 80uC for 2 min and
cooled to room temperature for primer annealing. Pyrosequencing
reactions were performed with the PyroMark Gold enzyme,
substrate and nucleotides using the PyroMark ID instrument
(Qiagen). Pyrosequencing data were analysed using Identifier
software (Qiagen) with a library constructed containing the
signature sequences of each gene from all subtypes to determine
the origin of each gene.
Sanger sequencing confirmation
RT-PCR products of all eight genes were amplified using
specific primers. Sequencing reactions of the PCR products were
carried out using BigDye Terminator (Applied Biosystems) on a
35006L Genetic Analyzer (Applied Biosystems) according to the
manufacturer’s recommendation. Sequences were analysed with
DNAStar Lasergene package v8.1.5.
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